Chimerix | Results Presentation Deck | 12 slides

Chimerix · 2022-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

12
every slide · same image gating as the playbook
01
Slide 1
Presented at ICAR on March 23, 2022 by Randall Lanier.front_matter
03
The slide uses a bubble chart-like visualization to compare the scale of outbreaks.frame_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
04
The slide uses a split-panel comparison format to bridge previous development (norovirus) with current application (SARS-CoV-2).establish_context
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
05
Includes chemical structure of CMX521.summarize
06
The table highlights residues involved in RNA/nucleotide binding (yellow) and catalysis (green). Red boxes indicate specific variations.analyze_data
07
The slide uses a phylogenetic tree to contextualize the efficacy of the drug against specific viral strains.analyze_data
08
The slide details the mouse-adapted model (MA10) and the specific dosing regimen for CMX521.illustrate_case
09
The slide presents two dot plots showing efficacy of CMX521 treatment at different hours post-infection (HPI).analyze_data
Open slide detailBeat · Solution (Provide relief)
10
The slide compares different treatment initiation times (-8, 0, +8, +16, +24 HPI) against a vehicle control.analyze_data
Open slide detailBeat · Solution (Provide relief)Loop · Before After
11
The slide uses a modular block layout to represent parallel workstreams.plan_implementation
Open slide detailBeat · Solution (Provide relief)